• Eric J. Yetter

Vision Innovation Partners ("VIP") - Buyer Spotlight

PE Firm

Vision Innovation Partners ("VIP"), formerly known as Chesapeake Eye Care and Laser Center, was formed when private equity firm Centre Partners acquired that practice in 2017. Centre is primarily a consumer products and services investor, but also has a special expertise in healthcare.


Vision Innovation Partners has grown throughout the Mid Atlantic region, with a heavy concentration in Maryland. It is one of the larger groups with seventeen acquisitions to date.


Baltimore, Maryland and surrounding areas

Washington, DC and surrounding areas (Chevy Chase, MD; Arlington, VA)

Annapolis, Maryland and surrounding areas

Scranton, PA

Transaction List

Eyes of York; York, PA

Baltimore Eye Physicians; Baltimore, MD

Omni Eye Specialists; Baltimore, MD

Carroll Vision Center; Westminster, MD (Physicians First Transaction)

Center for Total EyeCare; Westminster, MD (Physicians First Transaction)

Metropolitan Ophthalmology Associates; Chevy Chase, MD

Washington Eye Specialists; Washington, DC

Busack Eye Center; Frederick, MD

EyeCare Specialists; Scranton, PA

Malouf Eye Center; Camp Springs, MD

Maryland Eye Associates; Annapolis, MD

Maryland Vision Institute; Hagerstown, MD

Select Eye Care; Towson, MD

Arlington Eye Center; Arlington, VA

Chesapeake Eye Care and Laser Center; Annapolis, MD

Whitten Laser Eye; Washington, DC

To learn more, download our latest ophthalmology industry report entitled ...

"After a Strong First Quarter, 2021 Is Now Looking Like a True Window of Opportunity for Ophthalmology Deals"

click here to download

This post is for informational purposes only and does not constitute an offer, invitation, solicitation, or recommendation to buy, sell, subscribe for, or issue any securities. While the information provided herein is believed to be accurate and reliable, 127 Capital, LLC (“Physicians First”) makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.